| Literature DB >> 33040038 |
Faith Hyun Kyung Jeon1,2, Michelle Griffin3,2,4, Jajini Varghese3,4, Peter Edward Michael Butler3,2,4.
Abstract
Oro-facial fibrosis presents a significant disease burden in patients with systemic sclerosis, but there remains no established treatment modality. Autologous fat grafting is a minimally invasive surgical procedure that is now increasingly recognised for its regenerative capacity, propagating an expansion of heterogeneous indications beyond volume restoration, including fibrotic diseases such as systemic sclerosis. We present a 42-year-old woman with oro-facial involvement of systemic sclerosis leading to severe limitation in mouth opening and closure, with marked retraction of the lower lip and gingival display. We describe the reconstructive journey over a 12-year period, where the antifibrotic effect of autologous fat grafting served as the basis on which a series of surgical procedures were performed to achieve functional and aesthetic improvement. Autologous fat grafting provides a novel treatment modality for oro-facial skin fibrosis, previously considered a non-treatable disease manifestation of systemic sclerosis. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: connective tissue disease; mouth; plastic and reconstructive surgery; rheumatology
Mesh:
Year: 2020 PMID: 33040038 PMCID: PMC7552801 DOI: 10.1136/bcr-2020-236663
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X